{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:22:47Z","timestamp":1792794167456,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009543","name":"Pontificia Universidad Javeriana","doi-asserted-by":"publisher","award":["120289301011ZZ"],"award-info":[{"award-number":["120289301011ZZ"]}],"id":[{"id":"10.13039\/501100009543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009543","name":"Pontificia Universidad Javeriana","doi-asserted-by":"publisher","award":["InvestigarPUJ 20646"],"award-info":[{"award-number":["InvestigarPUJ 20646"]}],"id":[{"id":"10.13039\/501100009543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003402","name":"Fundaci\u00f3n Valle del Lili","doi-asserted-by":"publisher","award":["2025-ART-001"],"award-info":[{"award-number":["2025-ART-001"]}],"id":[{"id":"10.13039\/501100003402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002411","name":"Icesi University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ymgme.2026.109905","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:35:04Z","timestamp":1773826504000},"page":"109905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tay-Sachs disease models: From cellular and animal models to treatment perspectives"],"prefix":"10.1016","volume":"148","author":[{"given":"Diego A.","family":"Suarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s Felipe","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Pachajoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Granados-Villalobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Johana","family":"Espejo-Mojica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Seyrantepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Javier","family":"Alm\u00e9ciga-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2026.109905_bb0005","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jnn.2020.02.001","article-title":"Tay-Sachs disease","volume":"26","author":"Lopez Vasquez","year":"2020","journal-title":"J. Neonatal Nurs."},{"key":"10.1016\/j.ymgme.2026.109905_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176213","article-title":"GM2 gangliosidoses: clinical features, pathophysiological aspects, and current therapies","volume":"21","author":"Leal","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2026.109905_bb0015","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/jnr.23411","article-title":"Pathogenic role of ganglioside metabolism in neurodegenerative diseases","volume":"92","author":"Ariga","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymgme.2026.109905_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136195","article-title":"The GM2 gangliosidoses: unlocking the mysteries of pathogenesis and treatment","volume":"764","author":"Toro","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2026.109905_bb0025","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrneurol.2013.163","article-title":"Lysosomal storage diseases\u2014the horizon expands","volume":"9","author":"Boustany","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymgme.2026.109905_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0280650","article-title":"Autophagic flux is impaired in the brain tissue of Tay-Sachs disease mouse model","volume":"18","author":"Sengul","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2026.109905_bb0035","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/BJ20111451","article-title":"Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling","volume":"441","author":"Lee","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2026.109905_bb0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41591-021-01664-4","article-title":"AAV gene therapy for Tay-Sachs disease","volume":"28","author":"Flotte","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgme.2026.109905_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810672","article-title":"CRISPR\/nCas9-based genome editing on GM2 gangliosidoses fibroblasts via non-viral vectors","volume":"23","author":"Leal","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2026.109905_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadva.2021.100032","article-title":"Increased phosphorylation of HexM improves lysosomal uptake and potential for managing GM2 gangliosidoses","volume":"2","author":"Benzie","year":"2022","journal-title":"BBA Adv."},{"key":"10.1016\/j.ymgme.2026.109905_bb0055","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41434-019-0120-5","article-title":"A novel gene editing system to treat both Tay\u2013Sachs and Sandhoff diseases","volume":"27","author":"Ou","year":"2020","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2026.109905_bb0060","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ajmg.c.31849","article-title":"Human recombinant lysosomal \u03b2-hexosaminidases produced in Pichia pastoris efficiently reduced lipid accumulation in Tay-Sachs fibroblasts","volume":"184","author":"Espejo-Mojica","year":"2020","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"key":"10.1016\/j.ymgme.2026.109905_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55136-4","article-title":"Bi-functional IgG-lysosomal enzyme fusion proteins for brain drug delivery","volume":"9","author":"Boado","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2026.109905_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0315005","article-title":"Intracerebroventricular administration of a modified hexosaminidase ameliorates late-stage neurodegeneration in a GM2 mouse model","volume":"20","author":"Lopez","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2026.109905_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/jpm15050196","article-title":"Yeast-produced human recombinant lysosomal \u03b2-hexosaminidase efficiently rescues GM2 ganglioside accumulation in Tay\u2013Sachs disease","volume":"15","author":"Inci","year":"2025","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.ymgme.2026.109905_bb0080","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10545-010-9186-3","article-title":"Substrate reduction therapy with miglustat in chronic GM2 gangliosidosis type Sandhoff: results of a 3-year follow-up","volume":"33","author":"Masciullo","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2026.109905_bb0085","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ymgme.2010.11.163","article-title":"Pyrimethamine increases \u03b2-hexosaminidase A activity in patients with late onset Tay Sachs","volume":"102","author":"Osher","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109905_bb0090","doi-asserted-by":"crossref","first-page":"9297","DOI":"10.1039\/C7OB02281F","article-title":"In silico analyses of essential interactions of iminosugars with the Hex A active site and evaluation of their pharmacological chaperone effects for Tay\u2013Sachs disease","volume":"15","author":"Kato","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ymgme.2026.109905_bb0095","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1080\/14756366.2022.2073444","article-title":"sp2-iminosugars targeting human lysosomal \u03b2-hexosaminidase as pharmacological chaperone candidates for late-onset Tay-Sachs disease","volume":"37","author":"Gonz\u00e1lez-Cuesta","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ymgme.2026.109905_bb0100","doi-asserted-by":"crossref","DOI":"10.1172\/JCI183434","article-title":"CNS-targeted base editing of the major late-onset Tay-Sachs mutation alleviates disease in mice","volume":"135","author":"Allende","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2026.109905_bb0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12974-020-01947-6","article-title":"GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease","volume":"17","author":"Demir","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ymgme.2026.109905_bb0110","doi-asserted-by":"crossref","DOI":"10.1242\/bio.062045","article-title":"Generation of mice with combined Hexa Gly269Ser KI or KO and Neu3 KO alleles to create new models of GM2 gangliosidoses","volume":"14","author":"Barker","year":"2025","journal-title":"Biol. Open"},{"key":"10.1016\/j.ymgme.2026.109905_bb0115","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jcpa.2013.10.003","article-title":"GM2 gangliosidosis in British Jacob sheep","volume":"150","author":"Wessels","year":"2014","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.ymgme.2026.109905_bb0120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13023-018-0886-3","article-title":"Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease","volume":"13","author":"Vu","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.109905_bb0125","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1091\/mbc.E16-01-0012","article-title":"Tay\u2013Sachs disease mutations in HEXA target the \u03b1 chain of hexosaminidase A to endoplasmic reticulum\u2013associated degradation","volume":"27","author":"Dersh","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ymgme.2026.109905_bb0130","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1203\/00006450-197804000-00013","article-title":"Tay-Sachs disease: ultrastructural studies on cultured fibroblasts","volume":"12","author":"Wyatt","year":"1978","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2026.109905_bb0135","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1056\/NEJMoa2200587","article-title":"In utero enzyme-replacement therapy for infantile-onset Pompe\u2019s disease","volume":"387","author":"Cohen","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2026.109905_bb0140","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1038\/s41467-021-24443-8","article-title":"In utero adenine base editing corrects multi-organ pathology in a lethal lysosomal storage disease","volume":"12","author":"Bose","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymgme.2026.109905_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8980","article-title":"Tolerance induction and microglial engraftment after fetal therapy without conditioning in mice with mucopolysaccharidosis type VII","volume":"12","author":"Nguyen","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2026.109905_bb0150","first-page":"321","article-title":"Cultured skin fibroblasts in lipidoses. Enzymatic, histochemical, and ultrastructural relationship in Fabry\u2019s Tay-Sachs, and Sandhoff\u2019s diseases","volume":"104","author":"Yuasa","year":"1980","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.ymgme.2026.109905_bb0155","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00109-020-01935-6","article-title":"Lysosomal storage diseases: current therapies and future alternatives","volume":"98","author":"Leal","year":"2020","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ymgme.2026.109905_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/cells10113122","article-title":"L-arginine ameliorates defective autophagy in GM2 gangliosidoses by mTOR modulation","volume":"10","author":"Castej\u00f3n-Vega","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ymgme.2026.109905_bb0165","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1080\/10408398.2011.573885","article-title":"L-arginine and nitric oxide in CNS function and neurodegenerative diseases","volume":"53","author":"Virarkar","year":"2013","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.ymgme.2026.109905_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17050628","article-title":"Evaluation of the PP6D5 polymer as a novel non-viral vector in the development of a CRISPR\/nCas9-based gene therapy for Tay\u2013Sachs disease","volume":"17","author":"Guerrero-Vargas","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ymgme.2026.109905_bb0175","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neuroscience.2019.06.026","article-title":"Presynaptic dysfunction in neurons derived from Tay-Sachs iPSCs","volume":"414","author":"Matsushita","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.ymgme.2026.109905_bb0180","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.scr.2016.08.010","article-title":"Generation of HEXA -deficient hiPSCs from fibroblasts of a Tay-Sachs disease patient","volume":"17","author":"Liu","year":"2016","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.ymgme.2026.109905_bb0185","series-title":"Encyclopedia of Neuroscience","first-page":"895","article-title":"Tay\u2013Sachs disease","author":"Kolodny","year":"2009"},{"key":"10.1016\/j.ymgme.2026.109905_bb0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ymgme.2021.05.001","article-title":"A pathogenic HEXA missense variant in wild boars with Tay-Sachs disease","volume":"133","author":"Bertani","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109905_bb0195","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.ymgme.2016.11.128","article-title":"Long term survival of sheep with Tay-Sachs disease after intracranial delivery of a novel bicistronic AAV gene therapy vector","volume":"120","author":"Gray-Edwards","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109905_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136751","article-title":"Investigating immune responses to the scAAV9-HEXM gene therapy treatment in Tay\u2013Sachs disease and Sandhoff disease mouse models","volume":"22","author":"Kot","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2026.109905_bb0205","first-page":"428","article-title":"Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin","volume":"276","author":"Platt","year":"1997","journal-title":"Science (1979)"},{"key":"10.1016\/j.ymgme.2026.109905_bb0210","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.3390\/cells12242791","article-title":"Lipid-lowering drug gemfibrozil protects mice from Tay-Sachs disease via peroxisome proliferator-activated receptor \u03b1","volume":"12","author":"Raha","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ymgme.2026.109905_bb0215","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00687809","article-title":"GM2 gangliosidosis in a Japanese spaniel","volume":"67","author":"Cummings","year":"1985","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2026.109905_bb0220","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ymgme.2012.11.008","article-title":"GM2 gangliosidosis associated with a HEXA missense mutation in Japanese Chin dogs: a potential model for Tay Sachs disease","volume":"108","author":"Sanders","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109905_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-021-00276-z","article-title":"Efficient and precise generation of Tay\u2013Sachs disease model in rabbit by prime editing system","volume":"7","author":"Qian","year":"2021","journal-title":"Cell Discov."},{"key":"10.1016\/j.ymgme.2026.109905_bb0230","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jcpa.2012.06.008","article-title":"GM2 gangliosidosis in an adult pet rabbit","volume":"148","author":"Rickmeyer","year":"2013","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.ymgme.2026.109905_bb0235","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/BF00286657","article-title":"Prenatal diagnosis of Tay-Sachs disease. Reflectometry of hexosaminidase A, B, and C\/S bands on zymograms","volume":"65","author":"Kustermann-Kuhn","year":"1983","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2026.109905_bb0240","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.braindev.2009.01.007","article-title":"Unilaterally and rapidly progressing white matter lesion and elevated cytokines in a patient with Tay\u2013Sachs disease","volume":"32","author":"Hayase","year":"2010","journal-title":"Brain Dev."},{"key":"10.1016\/j.ymgme.2026.109905_bb0245","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-023-02637-1","article-title":"Biochemical and mutational analyses of HEXA in a cohort of Egyptian patients with infantile Tay-Sachs disease. Expansion of the mutation spectrum","volume":"18","author":"Ibrahim","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2026.109905_bb0250","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00439-003-1072-8","article-title":"Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: genetic drift as a robust and parsimonious hypothesis","volume":"114","author":"Frisch","year":"2004","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2026.109905_bb0255","article-title":"Naturally occurring GM2 gangliosidosis in two Muntjak deer with pathological and biochemical features of human classical Tay-Sachs disease (type B GM2 gangliosidosis)","volume":"1","author":"Fox","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2026.109905_bb0260","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ymgme.2008.06.010","article-title":"Spontaneous appearance of Tay\u2013Sachs disease in an animal model","volume":"95","author":"Zeng","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109905_bb0265","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1093\/hmg\/ddz127","article-title":"Large animal models contribute to the development of therapies for central and peripheral nervous system dysfunction in patients with lysosomal storage diseases","volume":"28","author":"Gurda","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2026.109905_bb0270","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ymgme.2010.08.006","article-title":"Tay-Sachs disease in Jacob sheep","volume":"101","author":"Torres","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109905_bb0275","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1089\/hum.2017.163","article-title":"Adeno-associated virus gene therapy in a sheep model of Tay\u2013Sachs disease","volume":"29","author":"Gray-Edwards","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2026.109905_bb0280","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ymgme.2021.08.009","article-title":"Natural history of Tay-Sachs disease in sheep","volume":"134","author":"Story","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2026.109905_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243006","article-title":"Natural history study of glycan accumulation in large animal models of GM2 gangliosidoses","volume":"15","author":"Cavender","year":"2020","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2026.109905_bb0290","first-page":"663","article-title":"The GM1 and GM2 gangliosidoses: natural history and progress toward therapy","volume":"13","author":"Regier","year":"2016","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.ymgme.2026.109905_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/5.1.1","article-title":"Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases","volume":"5","author":"Phaneuf","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2026.109905_bb0300","doi-asserted-by":"crossref","first-page":"9975","DOI":"10.1073\/pnas.91.21.9975","article-title":"Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease","volume":"91","author":"Yamanaka","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ymgme.2026.109905_bb0305","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/BF00309622","article-title":"Neuropathology of mice with targeted disruption of Hexa gene, a model of Tay-Sachs disease","volume":"89","author":"Taniike","year":"1995","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2026.109905_bb0310","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/BF00292433","article-title":"Disruption of murine Hexa gene leads to enzymatic deficiency and to neuronal lysosomal storage, similar to that observed in Tay-Sachs disease","volume":"6","author":"Cohen-Tannoudji","year":"1995","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.ymgme.2026.109905_bb0315","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng1095-170","article-title":"Mouse models of Tay\u2013Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism","volume":"11","author":"Sango","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2026.109905_bb0320","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.expneurol.2017.09.012","article-title":"Murine sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease","volume":"299","author":"Seyrantepe","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymgme.2026.109905_bb0325","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/hum.2016.013","article-title":"Novel vector design and hexosaminidase variant enabling self-complementary adeno-associated virus for the treatment of Tay-Sachs disease","volume":"27","author":"Karumuthil-Melethil","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2026.109905_bb0330","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2015.57","article-title":"Construction of a hybrid \u03b2-hexosaminidase subunit capable of forming stable homodimers that hydrolyze GM2 ganglioside in vivo","volume":"3","author":"Tropak","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymgme.2026.109905_bb0335","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13052-018-0563-0","article-title":"Possible strategies to cross the blood\u2013brain barrier","volume":"44","author":"Bellettato","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.ymgme.2026.109905_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101300","article-title":"Treating late-onset Tay Sachs disease: brain delivery with a dual trojan horse protein","volume":"32","author":"Osher","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymgme.2026.109905_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001118","article-title":"Mice doubly-deficient in lysosomal hexosaminidase A and neuraminidase 4 show epileptic crises and rapid neuronal loss","volume":"6","author":"Seyrantepe","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ymgme.2026.109905_bb0350","first-page":"72","article-title":"Neuraminidase-1 contributes significantly to the degradation of neuronal B-series gangliosides but not to the bypass of the catabolic block in Tay\u2013Sachs mouse models","volume":"4","author":"Timur","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.109905_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.892248","article-title":"Analysis of brain lipids in the early-onset Tay\u2013Sachs disease mouse model with the combined deficiency of \u03b2-hexosaminidase A and neuraminidase 3","volume":"9","author":"Can","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ymgme.2026.109905_bb0360","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00109-024-02498-6","article-title":"Abnormally accumulated GM2 ganglioside contributes to skeletal deformity in Tay-Sachs mice","volume":"102","author":"Demir","year":"2024","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ymgme.2026.109905_bb0365","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11033-025-10380-y","article-title":"Imbalance in redox homeostasis is associated with neurodegeneration in the murine model of Tay-Sachs disease","volume":"52","author":"Bas\u0131rl\u0131","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ymgme.2026.109905_bb0370","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11011-025-01553-6","article-title":"Combined treatment of ketogenic diet and propagermanium reduces neuroinflammation in Tay-Sachs disease mouse model","volume":"40","author":"Inci","year":"2025","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ymgme.2026.109905_bb0375","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/neurolint17070098","article-title":"Advances in diagnosis, pathological mechanisms, clinical impact, and future therapeutic perspectives in Tay\u2013Sachs disease","volume":"17","author":"Gonz\u00e1lez-S\u00e1nchez","year":"2025","journal-title":"Neurol. Int."},{"key":"10.1016\/j.ymgme.2026.109905_bb0380","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2511596122","article-title":"Engineered 3D immuno-glial-neurovascular human miBrain model","volume":"122","author":"Stanton","year":"2025","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226001885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226001885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:01:09Z","timestamp":1787670069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226001885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1096719226001885"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.109905","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tay-Sachs disease models: From cellular and animal models to treatment perspectives","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.109905","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109905"}}